Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-ß) Agonist, was Well-tolerated with Significant Reductions in Liver Fat at Week 12 in Non-cirrhotic MASH Patients in the Ongoing ...

Since MELD 3.0 was implemented in July 2023, a higher proportion of women are now on the liver transplant waitlist, and ...

Psychosocial factors associated with liver transplant candidates’ placement on the waiting list were identified via large ...

Among 64 patients who received immune checkpoint inhibitors, 78% had downstaging of their liver tumor to within Milan ...

A recent study reveals that people who drink only beer tend to have poorer diets and health habits compared to those who ...

Designed to treat end-stage liver disease, the company has been granted permission from the Spanish authorities to expand its ...

who discussed their findings at the November 15-19 meeting of the American Association for the Study of Liver Diseases. The ...

INTEGRIS-PSC featured in an oral late breaker presentationSOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, ...

Given the increasing prevalence and mortality rates, targeted strategies are needed to reduce this growing health burden in ...